chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a registered nurse referring to a patient of currently 62 years of age and unspecified gender. The patient's pertinent medical history and concomitant medications were not reported. On an unknown date, the patient was vaccinated with improperly stored dose of ZOSTAVAX, lot # L035283, expiry date: 15-DEC-2016 (dose, route of administration and anatomical location not reported). The dose of ZOSTAVAX underwent temperature excursion: 14.7F for 2 hours and 15 minutes. There were no previous temperature excursions. No symptoms were reported. No product quality complaint (PQC) was involved. No further information was provided. This is one of several reports from the same reporter. Additional information has been requested.
At 16:30 Patient complained of ears feeling stuffy and scratchy throat.  V/S BP 151/102, HR 93, 02 98 %. Water was giving to patient and she sat their for an additional 25 minutes while monitoring. V/S at 16:40 158/108, HR 87, at 16:55 V/S  BP 153/107, HR 89. Patient feels good to leave. No dizziness or bad reactions. Advised patient to call primary doctor to advise she received vaccines and had a slightly elevated blood pressure.
It affected him neurologically and he can't walk, nor stand without wanting to vomit.; It affected him neurologically and he can't walk, nor stand without wanting to vomit.; It affected him neurologically and he can't walk, nor stand without wanting to vomit.; It affected him neurologically and he can't walk, nor stand without wanting to vomit.; This is a spontaneous report from a non-contactable consumer (patient's wife) A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 11Jan2021 at SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient was hospitalized on 12Jan2021 and reported  that on unspecified date "affected him neurologically and he can not walk, nor stand without wanting to vomit. Everything, and I mean everything else has been ruled out". Events outcome were unknown. The action taken was not applicable. No follow-up attempts are possible; Information about batch/lot number cannot be obtained. No further information is expected.
Information has been received from a physician concerning a 12 month old male with a missing corpus callosum who on 01-JUN-2007 was vaccinated with measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). Concomitant vaccinations on the same day included varicella virus vaccine live (VARIVAX) and hepatitis A vaccine (inactive) (HAVRIX). Within 24 hours of receiving measles virus vaccine live (Enders-Edmonston) (+) mumps virus live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) the patient experienced fever and vomiting. The patient also seemed "to be in a daze and just not himself" which persists. The patient sought unspecified medical attention. Additional information has been requested.
hard to understand when speaking; hiccups; sore throat; diagnosed with stroke; dizziness, dizziness continued to get worse, not spinning, but quickly moving from side to side; feeling cold; A spontaneous report was received from a consumer concerning a 76 year old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination and experienced a stroke (Cerebrovascular accident),, dizziness, dizziness continued to get worse, not spinning, but quickly moving from side to side/ Dizziness , hard to understand when speaking/ Speech disorder, hiccups, sore throat (Oropharyngeal pain) and feeling cold (Feeling cold).   The patient's past medical history not provided. Concomitant product use was not provided by the reporter.   On 06 Mar 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (batch number: unknown) via intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On 07 Mar 2021, the patient experienced feeling cold which lasted for 48 hours. On 08 Mar 2021, the patient started experiencing dizziness, the dizziness continued to get worse until 13 Mar 2021 when it was described as not spinning, but quickly moving from side to side, and patient was taken to the emergency room. On 14 Mar 2021, the patient was diagnosed with a stroke, was extremely hard to understand when speaking, had hiccups and sore throat. The patient had been in the hospital since 14 Mar 2021.    The action taken with mRNA-1273 in response to the events was unknown.  The outcome of feeling cold was recovered on 09 Mar 2021. The outcome of stroke, hiccups and sore throat, hard to understand when speaking, dizziness was unknown at the time of this report.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.
pt recvd vax 20JAN95 & 48-72hrs p/vax pt exp fever,painful joints,upper resp congestion & was achy;sx were treated w/ASA & DPH;
blisters both upper arms and upper back that began approx 4 hours after injection...pt says the blisters went away and recurred today
Numbess and tingling in pinky finger and ring finger of left hand (shot was given in left arm)
Brief fainting spell after vaccination occurred immediately after 3rd vaccine. Was fine with #1, #2 vaccines.
pt recv vax 21DEC98 1030AM & mom gave APAP 11AM, 830PM & 130AM on 22DEC98, very warm temp not checked;mom noticed pt shook all over especially arms for about 30sec;
1st shingles shot about 9 months ago, did not realize there were shots; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (got the first shingles shot about 9 months ago.).   On an unknown date, the patient did not receive the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date:  06-JUL-2022 Reporter's comment :The patient reported that she did not realized that there were further shots to be taken. The patient also wanted to know if they should restart the series or if they should just get second  dose or what was the process she should follow. The patient reported that she had missed the second dose. Additional supportive information: Till the time of reporting, the patient did not receive the second dose of Shingrix, which led to incomplete course of vaccination. Follow-up would not possible as no contact details were available.
I had a headache most of the day and soon I felt flushed, my face felt flushed and red and sweating. I remembered this occurring prior a year ago so I checked my blood pressure with a personal monitor. I tried to home remedies and tried relaxing to decrease. The next day, I had a nurse at work check my blood pressure as well and it was in hypertension level 2 at 160/110 so I contacted my PCP. When I contacted my physician, it was still elevated in level 2 during my visit and they increased the dosage in the Lisinopril and it helped reduce my blood pressure, but not back to normal. So a week or so later, I called again and mentioned my levels only dropped to HBP Level 1, they added Amlodipine to my daily dosage as well and that helped regulate my blood pressure again to normal now.
A few minutes after receiving the flu vaccine, she reported to father that she "couldn't see" and felt dizzy. She laid supine on exam table for a few minutes & vitals stable. Then she was sitting for a few minutes. She said she felt much better. Vital stable. Walked out of office approximately 20 minutes after vaccine. She does have h/o feeling dizzy/faint after other vaccines.
Narrative: COVID infection following COVID vaccine series 01/16, Pfizer, dose #1 02/06, Pfizer, dose #2 08/05 pt cc; chills, cough, headache, loss of taste or smell, fatigue, myalgias, rhinorrhea, nasal congestion exposure; unknown 08/07 COVID swab, result; detected 08/08-08/16 pt symptoms continue 08/12 SARS-COV-2 LINEAGE result: B.1.6172.2 08/12 SARS-COV-2 CLADE reults: 21A Delta 08/17/ clinically resolve
PATIENT STATES HAS NAUSEA AND DIZZINESS ALONG WITH TINGLING SENSATION TO FACE AND LIPS. PULSE IS 100 AND REGULAR. PATIENT HAS NO SHORTNESS OF BREATH, NO RASH OR ITCHING. PATIENT WATCHED AND EXTRA 15 MINS BUT REFUSED TO GO FOR FURTHER TREATMENT.PATIENT INSTRUCTED TO FOLLOW UP WITH EMERGERGENY DEPARTMENT OR CLINIC IF HAD FURTHER NEDDS OR ISSUES DID NOT RESOLVE.
Injection site began getting red and hot per mom in the evening of 11-07-17. Child was brought to our office on 11-08-17 at 09:40 AM and was found to have a bright red area, that was hot to the touch measuring 10cm X 5cm. There was also a knot at the injection site that was 3cm X 3.5 cm. Child was given Cefdinir 250 mg/ 5ml with the directions to take 6 ml BID X 10 days. Also was told to take 7.5 ml of BENADRYL Q 6 hours. Child was rechecked on 11-09-17 11:20 AM and still had basically the same measurement of redness but it was only pink and the heat was totally gone. The knot had shrunk to approximately the size of a "pea".
This spontaneous report as received from a 42 year old female pharmacist refers herself. The patient's current conditions included dry skin and acetaminophen, PERCOCET allergy. The patient's medcal history included basal cell carcinoma and chickenpox (when she was younger). In 2014 (sometime between October and December 2014), after reconstituting ZOSTAVAX, the vaccine leaked and got on the patient's right hand. The patient washed both hands with soap and water. In approximately February 2015 (reported as 2 weeks ago), the patient experienced itchy rash on her lower back that might be spreading. The patient was reported as not recovered/not resolved (the patient's present status was reported as: rash on lower back). The relatedness between the event and ZOSTAVAX was not reported. This is one of several reports from the same reporter. Additional information is not expected, there was no consent to contact.
Hives; Bumps that are itchy; Itchiness; scratches to the point where it becomes swollen and one big 5 centimeter hive; lips (top & bottoms) have also started to swell; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives), SKIN SWELLING (Bumps that are itchy), PRURITUS (Itchiness), SCRATCH (scratches to the point where it becomes swollen and one big 5 centimeter hive) and LIP SWELLING (lips (top & bottoms) have also started to swell) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 014M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Feb-2021, the patient experienced URTICARIA (Hives), SKIN SWELLING (Bumps that are itchy), PRURITUS (Itchiness), SCRATCH (scratches to the point where it becomes swollen and one big 5 centimeter hive) and LIP SWELLING (lips (top & bottoms) have also started to swell). At the time of the report, URTICARIA (Hives), SKIN SWELLING (Bumps that are itchy), PRURITUS (Itchiness), SCRATCH (scratches to the point where it becomes swollen and one big 5 centimeter hive) and LIP SWELLING (lips (top & bottoms) have also started to swell) outcome was unknown.            Concomitant product use was not provided by the reporter. Treatment included as Benadryl.   This case was linked to MOD-2021-072643 (Patient Link).
hot skin all over body; prickly skin all over body; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FEELING HOT (hot skin all over body) and SKIN IRRITATION (prickly skin all over body) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Allergic reaction (I usually get this allergic reaction to medications/vaccination and get prednisone. I can't take prednisone with this.) since an unknown date. Concurrent medical conditions included Allergy NOS (I have lots of allergies).    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING HOT (hot skin all over body) and SKIN IRRITATION (prickly skin all over body). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event following immunisation, at an unspecified dose and frequency. At the time of the report, FEELING HOT (hot skin all over body) and SKIN IRRITATION (prickly skin all over body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were given    Reporter did not allow further contact
Lack of effect/Suspected vaccination failure; mild case of shingles; This case was reported by a consumer via call center representative and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix and Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.  Additional details were provided as follows: The patient had reported the case for himself. The age at vaccination was not reported. The patient had completed the Shingrix vaccination series about 3 years ago, but he got a mild case of shingles. This case was considered as suspected vaccination failure, as information about time to onset and laboratory test confirmation for shingles infection was unknown. The reporter did not consent to follow-up.
26MAY92 pt devel a scattered vesicular rash on arms, legs, lt side of back & rt shoulder, & itches; rash lasted until 2JUN92;
Episodes of paroxysmal supraventricular tachycardia requiring hospitalization with 3 ER visits
Patient kept calling wanting his second dose of vaccine even though he received the Janssen vaccine. Patient did not present his vaccine card to the nurse and did not state what vaccine he recieved at first. At administration of the shot and she gave him a moderna dose one month after the initial Janssen shot due to the patient stating he was here to get his second dose. Our Janssen vaccines were on pause at the time and it was a new staff member who had not been giving vaccines prior to this date. Patient is doing well and had no reaction after the incorrect administration.
Moderna COVID- 19 Vaccine EUA: one day after receiving vaccination patient presented to the emergency department with epigastric pain for three hours. Patient denies sweating, shortness of breath, nausea, vomiting, and diarrhea. Stated that soon after receiving vaccination experienced fever, chills, and myalgias. Initial vitals within normal ranges except for blood pressure of 158/77 mmHg. Patient administered antacids and lidocaine with symptom improvement. Repeat vital signs within normal ranges and patient discharged to home stable.
flu like symptoms; 100 degree temperature; Joint Ache; Nausea; migraine; This is a spontaneous report from a contactable consumer (patient). A 69-years-old female consumer received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number: EL9269and expiration date: Not available), via an unspecified route of administration in the right arm on 12Feb2021 at 09:45 AM as a single dose for COVID-19 immunisation. The patient was not pregnant. The patients medical history included lung cancer. The patient had sulpha-based medications allergy. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number: EL9263 and expiration date: Not available) via an unspecified route of administration in the right arm on 22Jan2021 at 15:30 PM. Prior to the vaccination, the patient was not diagnosed with COVID-19. No covid test post vaccination. No other vaccine in four weeks. The patient received Rosuvastatin, Vitamin D, Calcium, and daily multivitamins in two weeks. On 13Feb2021 at 19:00 PM, the patient experienced flu like symptoms, 100-degree temperature, joint aches, chills, nausea, and migraine. The patient did not receive any treatment for the events. The outcome of the event was recovered.
Resident received her booster shot in nursing home facility around 10AM 11/9/21.  Started to experience chills around 4:30pm.  Temp noted 101.7 oral. VS, resident placed in isolation, Rapid Covid test negative, Covid Nasal swab collected,  Tylenol given. Symptoms resolved within 24 hours. No further temp or c/o of chills.
4 months of age (administered on 29Jul2019 / 16 months of age (administered on 14Aug2020 / 19 months of age (administered on 13Nov2020; 4 months of age (administered on 29Jul2019 / 16 months of age (administered on 14Aug2020 / 19 months of age (administered on 13Nov2020; This case was reported by a nurse via call center representative and described the occurrence of drug dose administration interval too long in a 1-year-old female patient who received DTPa (Infanrix) (batch number D2KX9, expiry date 26th November 2021) for prophylaxis.   Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis, DTPa (Infanrix) (batch number 5CK5K, expiry date 17th January 2022) for prophylaxis and dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   Previously administered products included Infanrix (received 1st dose on 29th May 2019 at 8 weeks of age, batch number and expiration date were unknown) and Infanrix (received 2nd dose on 29th July 2019 at 4 month of age, batch number and expiration date were unknown).   On 13th November 2020, the patient received Infanrix and Infanrix Pre-Filled Syringe Device. On 14th August 2020, the patient received the 3rd dose of Infanrix and Infanrix Pre-Filled Syringe Device. On 14th August 2020, not applicable after receiving Infanrix and Infanrix Pre-Filled Syringe Device and unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced drug dose administration interval too long. On 13th November 2020, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long and drug dose administration interval too long were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The nurse reported that patient received 3rd dose of Infanrix at 16 months of age and booster dose at 19 months of age longer than recommended schedule, which led to lengthening of vaccine schedule. The first two doses were administered at a different doctor's office, the second two doses were administered at the reporter's facility. The reporter consented to follow up.
Pt stated that at time of administration she "felt medication being injected, felt medicine going in". Pt later stated that she had tenderness and soreness in that muscle group. Has persisted for 2 weeks.
Seen in ED,Patient will with reports of a globus sensation in his throat that started this afternoon 2/18, Patient with some inflammation of the uvula with mild erythema.Concern for old allergic reaction versus uvulitis. Pt has no other associated symptoms. Patient was treated with oral Decadron however spit this out, was then treated with IM Decadron. No other symptons. At time of discharge pt  was asymptomatic.
Right upper extremity diffuse, erythematous maculopapular rash. Right upper forearn also swollen. Amoxicillin/clavulanate 500 mg BID.
Information has been received from a licensed practical nurse concerning an 11 month old healthy female who on 2/5/98, 5 days before her first birthday, was vaccinated with a dose of varicella virus vaccine live (lot # 624441/1105E). On 5/18/04 it was reported that two recent varicella titers were negative. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
arm was sore; This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer or other non-HCP. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number and expiry date was not reported), dose 1 via an unspecified route of administration on 19Feb2021 as DOSE 1, SINGLE for COVID-19 immunization. The patients medical history and concomitant medications were not reported. On an unspecified date in Feb2021, the patients arm was sore. The patient was wondering when she would need to go back for second dose. Relayed 21 days between doses and said everything went well after vaccine just arm was sore. The patient was advised to contact facility of 1st dose to make 2nd dose appointment. The clinical outcome for the event was unknown.  Follow-up attempts are completed. No further information is expected.
dizzy, nausea, loss of appetite, headache, diarrhea, unable to leave bed for 2.5 days, fever, chills, body aches, swollen gland on right side of neck
Within 1 hour significant aching of joints/muscles. Following day muscles and joint stiffness.  Extended muscle and body aches as of day 4.
Seemingly local reaction with induration erythema, warmth within 24 hrs of vaccination which improved on its own (8-11cm) (L) arm.
1st Moderna dose was given at 0935. At approx 0940 ptient reported left arm tingling, radiating to back for neck and right side of face. Does report a hx of a sensory disorder and that she develops this same feeling normally but not as prevalent. Also reports left eye swelling which is new for her. BP 130/72. No SOB, troubles breathing, or any other symptoms. Patient was given Benadryl 50g po x 1. Within 30min symptoms improved.
My wife tested positive for COVID-19 on 11/02/2022. On 11/07/2022, I tested positive for COVID-19. She had more severe symptoms than I did. I experienced almost no symptoms. I had a slightly stuffy nose and was slightly fatigued but that only lasted a few days. On 11/09/2022, I called my doctor's office to request a prescription for PAXLOVID. He approved the prescription, and I began taking it that same day and continued for the suggested 5 days. On 11/13/2022, I then tested negative for COVID-19.
9/27 Chills and fever. Red/swollen injection site . Chills so bad my teeth were chattering. Fever 102 degrees - 104 degrees night after shot. Weak, shaky 9/28. Recovered by 9/29.
Information has been received from a registered nurse concerning a female pt with a maternal hx of multiple sclerosis who was vaccinated with Hep B vaccine. It was reported that the pt "developed lupus." In is unknown where the vaccination was received. Additional information has been requested. The pt's sister also had an adverse experience following exposure to hepatitis B vaccine.